ODMCX
Price
$11.04
Change
+$0.05 (+0.45%)
Updated
Jul 9 closing price
Net Assets
340.59M
VIMSX
Price
$77.34
Change
+$0.33 (+0.43%)
Updated
Jul 9 closing price
Net Assets
192.45B
Interact to see
Advertisement

ODMCX vs VIMSX

Header iconODMCX vs VIMSX Comparison
Open Charts ODMCX vs VIMSXBanner chart's image
JPMorgan SMID Cap Equity C
Price$11.04
Change+$0.05 (+0.45%)
VolumeN/A
Net Assets340.59M
Vanguard Mid Cap Index Investor
Price$77.34
Change+$0.33 (+0.43%)
VolumeN/A
Net Assets192.45B
ODMCX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ODMCX vs. VIMSX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ODMCX is a Buy and VIMSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 192B vs. ODMCX (341M). VIMSX pays higher dividends than ODMCX: VIMSX (1.40) vs ODMCX (0.00). ODMCX was incepted earlier than VIMSX: ODMCX (26 years) vs VIMSX (27 years). ODMCX (1.72) is less costly to investors than VIMSX (0.17). ODMCX is a more actively managed with annual turnover of: 39.00 vs. VIMSX (16.00). ODMCX has a lower initial minimum investment than VIMSX: ODMCX (1000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 16.95 vs. ODMCX (8.81). VIMSX return over 5 years is better than : 71.02 vs. ODMCX (-8.25).
ODMCXVIMSXODMCX / VIMSX
Total Expense Ratio1.590.17935%
Annual Report Gross Expense Ratio1.720.171,012%
Fund Existence26 years27 years-
Gain YTD0.0006.916-
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets341M192B0%
Annual Yield % from dividends0.001.40-
Returns for 1 year8.8116.9552%
Returns for 3 years0.7040.092%
Returns for 5 years-8.2571.02-12%
Returns for 10 years-41.84125.42-33%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSHA2.540.12
+4.96%
Taysha Gene Therapies
ACXP0.500.01
+2.35%
Acurx Pharmaceuticals
FIX535.027.60
+1.44%
Comfort Systems USA
FINW15.940.09
+0.54%
FinWise Bancorp
BANF130.050.21
+0.16%
BancFirst Corp